Scion Life Sciences
New York, USA · Seed → Growth
Their stated focus (public profile)
Scion Life Sciences is a New York City-based life sciences venture capital firm focused on founding and building exceptional biotechnology companies that discover and develop clinically transformational or curative medicines for serious and life-threatening diseases. The firm invests from seed stage through IPO and beyond, often as one of the largest ongoing investors, deploying up to $60 million or more per portfolio company. Their asset selection is built on three pillars: mature modality, well-understood biology and pathophysiology, and standalone viability. They source innovation internally, from academia, and from industry partners, prioritizing clinical impact over incremental advances.
Stages: Seed → Growth
Sectors: Life sciences
Check size: investments as small as a few thousand dollars in speculative incubation efforts and to cumulatively deploy $60 million or more over the life of each portfolio company investment
On file: 12 partners on record
Website: scionlifesciences.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.